Annals of Oncology, 31, S591-S591. Oxford University Press Mego, M, Huddart, R A, Voortman, J, Ong, M, Gedye, C, Gurney, H, Fay, A P, Bamias, A, Mellado Gonzalez, B, Loriot, Y, Merseburger, A S, Castellano Gauna, D, de Ducla, S, Pavlova, J, Fear, S & Sternberg, C N 2020, ' Prognostic effect of systemic immune-inflammation index (SII) in 987 patients with advanced/metastatic urinary tract carcinoma (mUTC) treated with atezolizumab in the real-world global SAUL study ', Annals of Oncology, vol. 31, pp. S591-S591 . https://doi.org/10.1016/j.annonc.2020.08.838